LINC01965: A Potential Drug Target and Biomarker (G107985928)

Target Name: LINC01965

NCBI ID: G107985928

LINC01965

Other Name(s): LINC01965 variant X1 | Long intergenic non-protein coding RNA 1965, transcript variant X1 | long intergenic non-protein coding RNA 1965 | LINC01965 variant X2 | Long intergenic non-protein coding RNA 1965, transcript variant X2

LINC01965: A Potential Drug Target and Biomarker

LINC01965 is a gene that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The gene was discovered through a screening process using a variety of computational tools and bioinformatics analysis.

The LINC01965 gene is located on chromosome 6 and encodes a protein known as LINC01965, which is a protein that is expressed in various tissues and organs throughout the body. The primary function of LINC01965 is not well understood, but it is known to play a role in the development and progression of various diseases.

One of the promising aspects of LINC01965 is its potential as a drug target. The LINC01965 gene has been shown to be involved in several cellular processes that are associated with the development of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

For example, LINC01965 has been shown to be involved in the regulation of cell growth, which is a critical process that is involved in the development of cancer. The LINC01965 gene has also been shown to be involved in the regulation of cell death, which is important for the regulation of neurodegenerative diseases.

In addition to its potential as a drug target, LINC01965 has also been shown to be a potential biomarker for several diseases. The LINC01965 gene has been shown to be expressed in a variety of tissues and organs, including brain, spinal cord, and muscle. This suggests that it may be a useful biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The identification of LINC01965 as a potential drug target and biomarker is an exciting finding that has the potential to lead to new treatments for a variety of diseases. Further research is needed to fully understand the function of LINC01965 and its potential as a drug target and biomarker.

In conclusion, LINC01965 is a gene that has the potential to be a drug target and biomarker for a variety of diseases. Further research is needed to fully understand its function and its potential as a treatment for a variety of conditions.

Protein Name: Long Intergenic Non-protein Coding RNA 1965

The "LINC01965 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01965 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets